Stem Cell-Related Stocks on the Move Following Cytori News (CYTX, STEM, PSTI, ASTM)

February 25, 2009 9:29 AM EST

Stem cell-related stocks are active this morning following news out of Cytori Therapeutics (Nasdaq: CYTX) that a recent study has suggested adipose tissue-derived stem and regenerative cells significantly reduce mortality and improve renal function in an acute kidney injury model.

Shares of Cytori are currently up about 4% to $3.22.

The news should be positive for the stem cell sector as a whole. Other stocks to watch on this news: StemCells (Nasdaq: STEM), Pluristem Therapeutics (Nasdaq: PSTI) and Aastrom Biosciences (Nasdaq: ASTM).


Related Categories

Corporate News
Insiders' Blog
Momentum Movers

Stocks Mentioned

ASTM 0.31

-0.01 -3.13%
Volume: 1,030,404
Track ASTM

CYTX 3.55

+0.05 +1.43%
Volume: 264,233
Track CYTX

PSTI 1.00

+0.05 +5.26%
Volume: 96,661
Track PSTI

STEM 1.13

-0.01 -0.88%
Volume: 980,958
Track STEM


Add Your Comment